MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Subcortical spectral perturbations during foot movements in PD patients with and without dystonia

    A. Nakhmani, C. Hurt, D. Kuhman, M. Wade, J. Olson, B. Guthrie, H. Walker (Birmingham, USA)

    Objective: To investigate subcortical brain oscillations at rest and during contralateral foot movements in PD patients with and without dystonia. Background: Dystonia is a painful,…
  • MDS Virtual Congress 2021

    PARKINSON’S DISEASE AND COVID-19 PANDEMIC: MODIFICATIONS IN MOTOR AND NON-MOTOR SYMPTOMS AND IN THE ACCESS TO MEDICAL AND NON-MEDICAL CONSULTATIONS AND TREATMENTS

    J. Bestoso, C V. Stefani, L. Ciancaglini, D. Bauso (Buenos Aires, Argentina)

    Objective: The objective was to determine in a group of PD patients their perception of how isolation measures during the pandemic affected their motor and…
  • MDS Virtual Congress 2021

    Dysphagia risk, respiratory muscle strength and maximal phonation time in elderly with Parkinson Disease in the initial stages

    R. Gonçalves, T. de Freitas, N. de Souza, J. Veras, J. Barbosa Neto, C. Araújo, C. Do Amaral, D. Dalles, L. Cardoso, P. Cortez, E. Andrade, M. Cardoso (Manaus, Brazil)

    Objective: To analyze the risk of dysphagia, respiratory muscle strength (RMS) and maximal phonation time (MPT) in elderly with Parkinson's disease (PD) in the initial stages…
  • MDS Virtual Congress 2021

    Clinical characteristics and factors associated musculoskeletal pain in Parkinson’s disease: A retrospective study from two centers in China

    J. Li, B. Zhu, Z. Gu, H. Zhang, S. Liu, S. Mei, S. Ji, H. Chen, E. Xu, P. Chan (Hefei, China)

    Objective: To investigate the distribution, clinical characteristics, and factors associated with MSP in a large sample of patients with PD. Background: Musculoskeletal pain (MSP) is…
  • MDS Virtual Congress 2021

    Vitamin D and Parkinson’s disease

    D. Novotnyy (Novosibirsk, Russian Federation)

    Objective: to study the correlation between vitamin D levels (deficiency) and clinical presentations in patients with Parkinson’s disease Background: previous studies throughout the world have…
  • MDS Virtual Congress 2021

    Evidence of Overlapping Pathology between Depression and Autonomic Dysfunction in Parkinson’s Disease

    M. Sklerov, E. Dayan, N. Browner, D. Rubinow, F. Frohlich (Chapel Hill, USA)

    Objective: To investigate the association between symptoms of depression and symptoms of autonomic dysfunction (AuD) in people with Parkinson’s disease (PD). Background: Depression and AuD…
  • MDS Virtual Congress 2021

    Social support moderates the burden of nonmotor but not motor symptoms among patients with Parkinson’s disease

    HJ. Yang, A. Kim, BS. Park (Ulsan, Republic of Korea)

    Objective: The present study tested the extent of moderating effects of patient-perceived social support on the association between motor and nonmotor symptoms and Health-related quality…
  • MDS Virtual Congress 2021

    Gut, nasal and oral dysbiosis in Parkinson’s disease

    S. Jo, W. Kang, YS. Hwang, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to identify the nasal, oral, and gut microbiota dysbiosis associated with the presence and clinical manifestations of Parkinson’s disease (PD) using 16s…
  • MDS Virtual Congress 2021

    Neuropsychiatric Issues in Parkinson’s Disease

    F. Aziouaz, Y. Mebrouk (Oujda, Morocco)

    Objective: The aim of this study is to analyze the epidemiology, clinical features and treatment approaches for NPS in PD. Background: Parkinson's disease (PD) is…
  • MDS Virtual Congress 2021

    Multimodal, longitudinal investigation in Dopa-responsive dystonia

    A. Steinmeier, MG. Pauly, DM. Al-Shorafat, G. Saranza, AE. Lang, N. Brüggemann, V. Tadic, C. Klein, K. Lohmann, MJN. Brown, C. Beste, A. Münchau, T. Bäumer, A. Weissbach (Lübeck, Germany)

    Objective: To perform a detailed longitudinal clinical and neurophysiological investigation in monogenic Dopa-responsive dystonia (DRD) patients with mutations in the guanosine triphosphate cyclohydrolase 1 (GCH1)…
  • « Previous Page
  • 1
  • …
  • 104
  • 105
  • 106
  • 107
  • 108
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley